Skip to main content
Sai Life Sciences Limited logo

Sai Life Sciences Limited — Investor Relations & Filings

Ticker · SAILIFE ISIN · INE570L01029 LEI · 335800JBS3NY25NIBC93 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 233 across all filing types
Latest filing 2025-08-05 Investor Presentation
Country IN India
Listing BSE.NS SAILIFE

About Sai Life Sciences Limited

https://www.sailife.com

Sai Life Sciences Limited is a full-service Contract Research, Development, and Manufacturing Organization (CRO-CDMO) that partners with global pharmaceutical and biotechnology innovators to accelerate the discovery, development, and commercialization of complex small molecules. The company provides an integrated platform of services spanning discovery chemistry and biology, DMPK, toxicology, process development, analytical R&D, and commercial-scale manufacturing. With a focus on operational excellence and regulatory compliance, it operates state-of-the-art R&D and manufacturing facilities. Its value proposition centers on the Sai Nxt initiative, which emphasizes investments in advanced technologies, expanded capacity, and a global delivery model designed to reduce time-to-market for novel therapeutics.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 85% confidence The document is a formal notification addressed to stock exchanges (BSE and NSE) about the schedule of meetings with analysts and investors. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and explicitly states that no new presentation will be made and no unpublished price sensitive information will be discussed. The content is an announcement of an upcoming investor meeting rather than a report or transcript of the meeting itself. It does not contain financial data, earnings, or detailed presentations. Therefore, it fits the category of an Investor Presentation announcement or meeting schedule. However, since it explicitly states no presentation will be made and is simply an intimation of the schedule, it aligns best with the category of Investor Presentation (IP) as it relates to investor relations and scheduled meetings with analysts/investors under regulatory compliance.
2025-08-05 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 85% confidence The document is a notification to stock exchanges about the schedule of an upcoming earnings conference call for the quarter ended 30 June 2025. It includes details about the date, time, dial-in numbers, and management participants for the call. The document does not contain actual financial results or detailed financial statements but rather announces the event where such results will be discussed. The document length is 4104 characters, which is relatively short and consistent with an announcement rather than a full report or transcript. Therefore, this document is best classified as a Call Transcript announcement or invitation, but since it is only announcing the call and not providing the transcript itself, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement. However, given the specific nature of announcing an earnings conference call, the most appropriate classification is Call Transcript (CT) as it relates directly to the earnings call event.
2025-07-23 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the allotment of equity shares under the company's Management ESOP Plan 2018. It references compliance with SEBI regulations, specifically Regulation 30 of SEBI (LODR) Regulations, 2015, and provides detailed disclosures about the share allotment, including number of shares, exercise price, and other regulatory details. The document is not a financial report, earnings release, or management discussion but rather an announcement of a capital change event (allotment of shares upon exercise of stock options). The content fits the category of a Share Issue/Capital Change announcement, as it informs about new shares issued and related details. The document length (8312 characters) and detailed regulatory disclosures support this classification rather than a brief notice or a report publication announcement.
2025-07-23 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-07-21 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice from Sai Life Sciences Limited informing stock exchanges about an upcoming Board Meeting scheduled for August 7, 2025. The purpose of the meeting includes consideration and approval of unaudited financial results for the quarter ended June 30, 2025. The document also mentions the closure of the trading window for insiders. The document is short (1872 characters) and serves as an announcement of a future event rather than containing any financial data or results itself. It does not contain actual financial statements or detailed analysis, nor is it a transcript or report. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement informing the market about the board meeting and related compliance matters.
2025-07-21 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate submitted under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2025. It is issued by the Registrar and Share Transfer Agent certifying details of securities dematerialized/rematerialized during the quarter. The document is addressed to stock exchanges and is a compliance certificate rather than a financial report or announcement of financial results. The document length is 3741 characters, which is relatively short and primarily serves as a regulatory compliance filing. It does not contain financial statements, management discussion, or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS) as a compliance certificate submission under SEBI regulations.
2025-07-14 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.